COSMOS Pharmaceutical Corporation Stock price

Equities

3349

JP3298400007

Drug Retailers

Delayed Japan Exchange 11:57:04 2023-12-04 pm EST Intraday chart for COSMOS Pharmaceutical Corporation 5-day change 1st Jan Change
16,150 JPY +0.53% +4.06% +20.95%
Sales 2024 * 942B 6.4B Sales 2025 * 1,021B 6.93B Capitalization 636B 4.32B
Net income 2024 * 24.66B 167M Net income 2025 * 26.75B 182M EV / Sales 2024 *
0,65x
Net cash position 2024 * 27.03B 184M Net cash position 2025 * 31.54B 214M EV / Sales 2025 *
0,59x
P/E ratio 2024 *
25,8x
P/E ratio 2025 *
23,8x
Employees -
Yield 2024 *
0,76%
Yield 2025 *
0,85%
Free-Float 47.5%
More Fundamentals * Assessed data
Dynamic Chart
Interim dividend FA
Cosmos Pharmaceutical’s Attributable Profit up marginally by 0.4% in Fiscal Q1 After Opening New Stores MT
COSMOS Pharmaceutical Corporation Reports Earnings Results for the First Quarter Ended August 31, 2023 CI
COSMOS Pharmaceutical Corporation Provides Consolidated Earnings Guidance for the First Half and Full Year of Fiscal Year Ending May 31, 2024 CI
Cosmos Attributable Profit Increases 2.8% in Fiscal Year 2023 MT
COSMOS Pharmaceutical Corporation Announces Year-End Dividend for the Year Ended May 31, 2023, Payable on August 3, 2023; Provides Dividend Guidance for the Second Quarter-End and Full Year of Full Year Ending May 31, 2024 CI
COSMOS Pharmaceutical Corporation Provides Consolidated Earnings Guidance for the First Half and Full Year of Fiscal Year Ending May 31, 2024 CI
Final dividend FA
Cosmos Pharma's Attributable Profit Slides 1% in Fiscal Nine Months Amid New Store Openings MT
COSMOS Pharmaceutical Corporation Provides Consolidated Earnings Guidance for the Fiscal Year Ending May 31, 2023 CI
COSMOS Pharmaceutical Corporation Provides Dividend Guidance for the Fiscal year ending May 31, 2023 CI
Cosmos Pharma Books Marginal Rise in Fiscal H1 Attributable Profit Amid New Store Openings, Low-cost Strategy MT
COSMOS Pharmaceutical Corporation Announces Dividend for the Second Quarter of Fiscal 2023; Provides Dividend Guidance for the Full Year of Fiscal Year Ending May 31, 2023 CI
Cosmos Pharmaceutical Corporation Provides Earnings Forecast for the Fiscal Year Ending May 31, 2023 CI
Interim dividend FA
More news
1 day+1.58%
1 week+3.78%
Current month+2.65%
1 month+1.68%
3 months-6.24%
6 months+16.24%
Current year+20.43%
More quotes
1 week
15 415.00
Extreme 15415
16 070.00
1 month
15 180.00
Extreme 15180
16 160.00
Current year
11 430.00
Extreme 11430
17 440.00
1 year
11 430.00
Extreme 11430
17 440.00
3 years
10 770.00
Extreme 10770
20 700.00
5 years
8 425.00
Extreme 8425
20 700.00
10 years
5 040.00
Extreme 5040
20 700.00
More quotes
Managers TitleAgeSince
President 43 2003
Director of Finance/CFO 58 1994
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Director/Board Member 50 2005
Director/Board Member 52 1998
Director of Finance/CFO 58 1994
More insiders
Date Price Change Volume
23-12-04 16,150 +0.53% 78 700
23-12-04 16,065 +1.58% 218,300
23-12-01 15,815 +1.05% 136,600
23-11-30 15,650 -1.07% 187,100
23-11-29 15,820 +2.03% 497,800

Delayed Quote Japan Exchange, December 04, 2023 at 01:00 am EST

More quotes
COSMOS Pharmaceutical Corporation is a company primarily engaged in the operation of drug stores. The Company offers medical goods, including general self-medication products, tonic drinks, oral care products, nursing care products, vitamin supplements, health food products, diet food and dispensing. Cosmetic products include cosmetic products for women and men, hair care products and bath agents. Miscellaneous goods include baby goods, detergents, insecticides, deodorizers, bath goods, toiletries, cookware, gardening goods, automobile goods and clothing products. General food products include processed food products, daily food products, seasonings, confectionery, non-alcoholic beverages and alcoholic beverages. It also provides tobacco and others.
Calendar
More about the company
Trading Rating :
Investor Rating :
ESG Refinitiv :
D+
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
11
Last Close Price
16,065JPY
Average target price
16,533.64JPY
Spread / Average Target
+2.92%
Consensus
  1. Stock
  2. Equities
  3. Stock COSMOS Pharmaceutical Corporation - Japan Exchange
The best tools reserved for subscribers to boost the performance of your investments!
Optimize my profits
fermer